Nektar Therapeutics (NKTR)

Trade NKTR now with
2/28/2019 4:12:55 PM Nektar Therapeutics Q4 Loss/share $0.57 Vs. Loss $0.21 Year Ago
1/3/2019 7:01:26 AM ImaginAb Enters Non-exclusive License And Clinical Trial Collaboration With Nektar Therapeutics
11/14/2018 9:02:48 AM Nektar Appoints Wei Lin As SVP Of Clinical Development And Head Of Nektar's Oncology Programs
11/7/2018 4:11:29 PM Nektar Therapeutics Q3 Loss Per Share $0.56 Vs EPS $0.37 Last Year
11/6/2018 8:34:07 AM Nektar Therapeutics And Pfizer Announce Clinical Oncology Collaboration
10/2/2018 8:03:59 AM Nektar Therapeutics To Present Ten Clinical And Preclinical Data Presentations Across Immuno-oncology Portfolio
10/1/2018 11:35:34 PM Nektar Therapeutics: Karin Eastham To Join Board, Dennis Winger To Retire
9/24/2018 7:02:00 AM BioXcel Therapeutics Expands Immuno-Oncology Partnership With Nektar Into Clinical Development In Pancreatic Cancer
8/9/2018 10:14:19 AM William Blair Is Increasing Nektar Therapeutics (NKTR) FY20 Estimate To -3.06 From -3.82
8/9/2018 10:14:03 AM William Blair Is Raising Nektar Therapeutics (NKTR) FY19 Estimate To -2.69 From -3.38
8/9/2018 10:13:45 AM William Blair Is Raising Nektar Therapeutics (NKTR) FY18 Estimate To 3.22 From 3.09
8/9/2018 10:13:05 AM William Blair Reiterates Nektar Therapeutics (NKTR) At Outperform